nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—SLCO1B3—Conjugated Estrogens—osteoporosis	0.131	0.204	CbGbCtD
Telmisartan—SLCO1B3—Estradiol—osteoporosis	0.115	0.179	CbGbCtD
Telmisartan—ABCC2—Ethinyl Estradiol—osteoporosis	0.0911	0.142	CbGbCtD
Telmisartan—ABCC2—Conjugated Estrogens—osteoporosis	0.0668	0.104	CbGbCtD
Telmisartan—ABCG2—Conjugated Estrogens—osteoporosis	0.0604	0.0944	CbGbCtD
Telmisartan—ABCG2—Estradiol—osteoporosis	0.0531	0.0828	CbGbCtD
Telmisartan—ABCB1—Ethinyl Estradiol—osteoporosis	0.0297	0.0464	CbGbCtD
Telmisartan—CYP2C19—Cholecalciferol—osteoporosis	0.0294	0.0459	CbGbCtD
Telmisartan—CYP2C19—Estradiol—osteoporosis	0.0237	0.037	CbGbCtD
Telmisartan—ABCB1—Conjugated Estrogens—osteoporosis	0.0218	0.034	CbGbCtD
Telmisartan—ABCB1—Estradiol—osteoporosis	0.0191	0.0299	CbGbCtD
Telmisartan—Losartan—ACE—osteoporosis	0.000321	1	CrCbGaD
Telmisartan—Dyspnoea—Risedronate—osteoporosis	0.000169	0.000572	CcSEcCtD
Telmisartan—Hypotension—Pamidronate—osteoporosis	0.000169	0.00057	CcSEcCtD
Telmisartan—Dry mouth—Zoledronate—osteoporosis	0.000168	0.000569	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000168	0.000568	CcSEcCtD
Telmisartan—Fatigue—Ethinyl Estradiol—osteoporosis	0.000168	0.000568	CcSEcCtD
Telmisartan—Pruritus—Alendronate—osteoporosis	0.000168	0.000566	CcSEcCtD
Telmisartan—Dyspepsia—Risedronate—osteoporosis	0.000167	0.000565	CcSEcCtD
Telmisartan—Eye disorder—Estradiol—osteoporosis	0.000167	0.000565	CcSEcCtD
Telmisartan—Tinnitus—Estradiol—osteoporosis	0.000167	0.000564	CcSEcCtD
Telmisartan—Constipation—Ethinyl Estradiol—osteoporosis	0.000167	0.000563	CcSEcCtD
Telmisartan—Hypersensitivity—Calcitriol—osteoporosis	0.000166	0.000562	CcSEcCtD
Telmisartan—Cardiac disorder—Estradiol—osteoporosis	0.000166	0.000561	CcSEcCtD
Telmisartan—Flushing—Estradiol—osteoporosis	0.000166	0.000561	CcSEcCtD
Telmisartan—Chest pain—Conjugated Estrogens—osteoporosis	0.000166	0.00056	CcSEcCtD
Telmisartan—Myalgia—Conjugated Estrogens—osteoporosis	0.000166	0.00056	CcSEcCtD
Telmisartan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000166	0.00056	CcSEcCtD
Telmisartan—Asthenia—Ibandronate—osteoporosis	0.000165	0.000559	CcSEcCtD
Telmisartan—Anxiety—Conjugated Estrogens—osteoporosis	0.000165	0.000558	CcSEcCtD
Telmisartan—Nausea—Etidronic acid—osteoporosis	0.000165	0.000558	CcSEcCtD
Telmisartan—Oedema—Zoledronate—osteoporosis	0.000165	0.000557	CcSEcCtD
Telmisartan—Anaphylactic shock—Zoledronate—osteoporosis	0.000165	0.000557	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000165	0.000556	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000165	0.000556	CcSEcCtD
Telmisartan—Diarrhoea—Estropipate—osteoporosis	0.000165	0.000556	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000164	0.000554	CcSEcCtD
Telmisartan—Infection—Zoledronate—osteoporosis	0.000164	0.000554	CcSEcCtD
Telmisartan—Fatigue—Risedronate—osteoporosis	0.000164	0.000553	CcSEcCtD
Telmisartan—Insomnia—Pamidronate—osteoporosis	0.000163	0.000552	CcSEcCtD
Telmisartan—Pruritus—Ibandronate—osteoporosis	0.000163	0.000551	CcSEcCtD
Telmisartan—Pain—Risedronate—osteoporosis	0.000163	0.000549	CcSEcCtD
Telmisartan—Constipation—Risedronate—osteoporosis	0.000163	0.000549	CcSEcCtD
Telmisartan—Angiopathy—Estradiol—osteoporosis	0.000162	0.000548	CcSEcCtD
Telmisartan—Shock—Zoledronate—osteoporosis	0.000162	0.000548	CcSEcCtD
Telmisartan—Paraesthesia—Pamidronate—osteoporosis	0.000162	0.000548	CcSEcCtD
Telmisartan—Diarrhoea—Alendronate—osteoporosis	0.000162	0.000547	CcSEcCtD
Telmisartan—Asthenia—Calcitriol—osteoporosis	0.000162	0.000547	CcSEcCtD
Telmisartan—Nervous system disorder—Zoledronate—osteoporosis	0.000162	0.000547	CcSEcCtD
Telmisartan—Immune system disorder—Estradiol—osteoporosis	0.000162	0.000546	CcSEcCtD
Telmisartan—Thrombocytopenia—Zoledronate—osteoporosis	0.000162	0.000546	CcSEcCtD
Telmisartan—Mediastinal disorder—Estradiol—osteoporosis	0.000161	0.000545	CcSEcCtD
Telmisartan—Dyspnoea—Pamidronate—osteoporosis	0.000161	0.000544	CcSEcCtD
Telmisartan—Tachycardia—Zoledronate—osteoporosis	0.000161	0.000544	CcSEcCtD
Telmisartan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000161	0.000542	CcSEcCtD
Telmisartan—Chills—Estradiol—osteoporosis	0.000161	0.000542	CcSEcCtD
Telmisartan—Somnolence—Pamidronate—osteoporosis	0.000161	0.000542	CcSEcCtD
Telmisartan—Skin disorder—Zoledronate—osteoporosis	0.00016	0.000541	CcSEcCtD
Telmisartan—Pruritus—Calcitriol—osteoporosis	0.00016	0.000539	CcSEcCtD
Telmisartan—Hyperhidrosis—Zoledronate—osteoporosis	0.00016	0.000539	CcSEcCtD
Telmisartan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000159	0.000538	CcSEcCtD
Telmisartan—Diarrhoea—Raloxifene—osteoporosis	0.000159	0.000538	CcSEcCtD
Telmisartan—Dyspepsia—Pamidronate—osteoporosis	0.000159	0.000537	CcSEcCtD
Telmisartan—Dizziness—Estropipate—osteoporosis	0.000159	0.000537	CcSEcCtD
Telmisartan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000159	0.000537	CcSEcCtD
Telmisartan—Oedema—Conjugated Estrogens—osteoporosis	0.000159	0.000537	CcSEcCtD
Telmisartan—Infection—Conjugated Estrogens—osteoporosis	0.000158	0.000533	CcSEcCtD
Telmisartan—Diarrhoea—Ibandronate—osteoporosis	0.000158	0.000533	CcSEcCtD
Telmisartan—Anorexia—Zoledronate—osteoporosis	0.000157	0.000531	CcSEcCtD
Telmisartan—Decreased appetite—Pamidronate—osteoporosis	0.000157	0.00053	CcSEcCtD
Telmisartan—Mental disorder—Estradiol—osteoporosis	0.000157	0.00053	CcSEcCtD
Telmisartan—Dizziness—Alendronate—osteoporosis	0.000157	0.000529	CcSEcCtD
Telmisartan—Shock—Conjugated Estrogens—osteoporosis	0.000156	0.000528	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000156	0.000527	CcSEcCtD
Telmisartan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000156	0.000526	CcSEcCtD
Telmisartan—Erythema—Estradiol—osteoporosis	0.000156	0.000526	CcSEcCtD
Telmisartan—Malnutrition—Estradiol—osteoporosis	0.000156	0.000526	CcSEcCtD
Telmisartan—Fatigue—Pamidronate—osteoporosis	0.000156	0.000526	CcSEcCtD
Telmisartan—Gastrointestinal pain—Risedronate—osteoporosis	0.000155	0.000525	CcSEcCtD
Telmisartan—Tachycardia—Conjugated Estrogens—osteoporosis	0.000155	0.000524	CcSEcCtD
Telmisartan—Urticaria—Ethinyl Estradiol—osteoporosis	0.000155	0.000523	CcSEcCtD
Telmisartan—Pain—Pamidronate—osteoporosis	0.000155	0.000522	CcSEcCtD
Telmisartan—Constipation—Pamidronate—osteoporosis	0.000155	0.000522	CcSEcCtD
Telmisartan—Diarrhoea—Calcitriol—osteoporosis	0.000154	0.000522	CcSEcCtD
Telmisartan—Skin disorder—Conjugated Estrogens—osteoporosis	0.000154	0.000521	CcSEcCtD
Telmisartan—Hypotension—Zoledronate—osteoporosis	0.000154	0.000521	CcSEcCtD
Telmisartan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000154	0.00052	CcSEcCtD
Telmisartan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000154	0.00052	CcSEcCtD
Telmisartan—Dizziness—Raloxifene—osteoporosis	0.000154	0.00052	CcSEcCtD
Telmisartan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000154	0.000519	CcSEcCtD
Telmisartan—Flatulence—Estradiol—osteoporosis	0.000154	0.000519	CcSEcCtD
Telmisartan—Tension—Estradiol—osteoporosis	0.000153	0.000516	CcSEcCtD
Telmisartan—Vomiting—Estropipate—osteoporosis	0.000153	0.000516	CcSEcCtD
Telmisartan—Dysgeusia—Estradiol—osteoporosis	0.000153	0.000515	CcSEcCtD
Telmisartan—Dizziness—Ibandronate—osteoporosis	0.000153	0.000515	CcSEcCtD
Telmisartan—Rash—Estropipate—osteoporosis	0.000152	0.000512	CcSEcCtD
Telmisartan—Dermatitis—Estropipate—osteoporosis	0.000152	0.000512	CcSEcCtD
Telmisartan—Anorexia—Conjugated Estrogens—osteoporosis	0.000152	0.000512	CcSEcCtD
Telmisartan—Nervousness—Estradiol—osteoporosis	0.000151	0.000511	CcSEcCtD
Telmisartan—Urticaria—Risedronate—osteoporosis	0.000151	0.00051	CcSEcCtD
Telmisartan—Back pain—Estradiol—osteoporosis	0.000151	0.000509	CcSEcCtD
Telmisartan—Headache—Estropipate—osteoporosis	0.000151	0.000509	CcSEcCtD
Telmisartan—Vomiting—Alendronate—osteoporosis	0.000151	0.000509	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00015	0.000508	CcSEcCtD
Telmisartan—Body temperature increased—Risedronate—osteoporosis	0.00015	0.000507	CcSEcCtD
Telmisartan—Abdominal pain—Risedronate—osteoporosis	0.00015	0.000507	CcSEcCtD
Telmisartan—Muscle spasms—Estradiol—osteoporosis	0.00015	0.000506	CcSEcCtD
Telmisartan—Rash—Alendronate—osteoporosis	0.000149	0.000504	CcSEcCtD
Telmisartan—Insomnia—Zoledronate—osteoporosis	0.000149	0.000504	CcSEcCtD
Telmisartan—Dermatitis—Alendronate—osteoporosis	0.000149	0.000504	CcSEcCtD
Telmisartan—Feeling abnormal—Pamidronate—osteoporosis	0.000149	0.000503	CcSEcCtD
Telmisartan—Hypotension—Conjugated Estrogens—osteoporosis	0.000149	0.000501	CcSEcCtD
Telmisartan—Headache—Alendronate—osteoporosis	0.000148	0.000501	CcSEcCtD
Telmisartan—Paraesthesia—Zoledronate—osteoporosis	0.000148	0.0005	CcSEcCtD
Telmisartan—Vomiting—Raloxifene—osteoporosis	0.000148	0.0005	CcSEcCtD
Telmisartan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000148	0.000499	CcSEcCtD
Telmisartan—Dyspnoea—Zoledronate—osteoporosis	0.000147	0.000497	CcSEcCtD
Telmisartan—Rash—Raloxifene—osteoporosis	0.000147	0.000496	CcSEcCtD
Telmisartan—Dermatitis—Raloxifene—osteoporosis	0.000147	0.000496	CcSEcCtD
Telmisartan—Somnolence—Zoledronate—osteoporosis	0.000147	0.000495	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—MGLL—osteoporosis	0.000147	0.00233	CbGpPWpGaD
Telmisartan—Vomiting—Ibandronate—osteoporosis	0.000147	0.000495	CcSEcCtD
Telmisartan—Headache—Raloxifene—osteoporosis	0.000146	0.000493	CcSEcCtD
Telmisartan—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	0.000146	0.00231	CbGpPWpGaD
Telmisartan—Rash—Ibandronate—osteoporosis	0.000145	0.000491	CcSEcCtD
Telmisartan—Dermatitis—Ibandronate—osteoporosis	0.000145	0.000491	CcSEcCtD
Telmisartan—Dyspepsia—Zoledronate—osteoporosis	0.000145	0.000491	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000145	0.000489	CcSEcCtD
Telmisartan—Ill-defined disorder—Estradiol—osteoporosis	0.000145	0.000488	CcSEcCtD
Telmisartan—Headache—Ibandronate—osteoporosis	0.000145	0.000488	CcSEcCtD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000144	0.00229	CbGpPWpGaD
Telmisartan—Insomnia—Conjugated Estrogens—osteoporosis	0.000144	0.000485	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	0.000144	0.00228	CbGpPWpGaD
Telmisartan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000144	0.000485	CcSEcCtD
Telmisartan—Vomiting—Calcitriol—osteoporosis	0.000144	0.000485	CcSEcCtD
Telmisartan—Decreased appetite—Zoledronate—osteoporosis	0.000143	0.000484	CcSEcCtD
Telmisartan—Nausea—Estropipate—osteoporosis	0.000143	0.000482	CcSEcCtD
Telmisartan—Abdominal pain—Pamidronate—osteoporosis	0.000143	0.000482	CcSEcCtD
Telmisartan—Body temperature increased—Pamidronate—osteoporosis	0.000143	0.000482	CcSEcCtD
Telmisartan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000143	0.000482	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000143	0.000481	CcSEcCtD
Telmisartan—Angioedema—Estradiol—osteoporosis	0.000142	0.000481	CcSEcCtD
Telmisartan—Rash—Calcitriol—osteoporosis	0.000142	0.000481	CcSEcCtD
Telmisartan—Fatigue—Zoledronate—osteoporosis	0.000142	0.00048	CcSEcCtD
Telmisartan—Dermatitis—Calcitriol—osteoporosis	0.000142	0.00048	CcSEcCtD
Telmisartan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000142	0.000478	CcSEcCtD
Telmisartan—Headache—Calcitriol—osteoporosis	0.000141	0.000478	CcSEcCtD
Telmisartan—Somnolence—Conjugated Estrogens—osteoporosis	0.000141	0.000477	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—POMC—osteoporosis	0.000141	0.00224	CbGpPWpGaD
Telmisartan—Pain—Zoledronate—osteoporosis	0.000141	0.000477	CcSEcCtD
Telmisartan—Constipation—Zoledronate—osteoporosis	0.000141	0.000477	CcSEcCtD
Telmisartan—Nausea—Alendronate—osteoporosis	0.000141	0.000475	CcSEcCtD
Telmisartan—Malaise—Estradiol—osteoporosis	0.000141	0.000475	CcSEcCtD
Telmisartan—Hypersensitivity—Risedronate—osteoporosis	0.00014	0.000473	CcSEcCtD
Telmisartan—Vertigo—Estradiol—osteoporosis	0.00014	0.000473	CcSEcCtD
Telmisartan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00014	0.000472	CcSEcCtD
Telmisartan—Asthenia—Ethinyl Estradiol—osteoporosis	0.00014	0.000472	CcSEcCtD
Telmisartan—Syncope—Estradiol—osteoporosis	0.00014	0.000472	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000138	0.0022	CbGpPWpGaD
Telmisartan—Nausea—Raloxifene—osteoporosis	0.000138	0.000467	CcSEcCtD
Telmisartan—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000138	0.000466	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000138	0.00219	CbGpPWpGaD
Telmisartan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000138	0.000466	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CALCA—osteoporosis	0.000138	0.00219	CbGpPWpGaD
Telmisartan—Palpitations—Estradiol—osteoporosis	0.000138	0.000465	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000137	0.000463	CcSEcCtD
Telmisartan—Fatigue—Conjugated Estrogens—osteoporosis	0.000137	0.000463	CcSEcCtD
Telmisartan—Nausea—Ibandronate—osteoporosis	0.000137	0.000463	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—IGF1—osteoporosis	0.000137	0.00218	CbGpPWpGaD
Telmisartan—Loss of consciousness—Estradiol—osteoporosis	0.000137	0.000463	CcSEcCtD
Telmisartan—Asthenia—Risedronate—osteoporosis	0.000136	0.00046	CcSEcCtD
Telmisartan—Feeling abnormal—Zoledronate—osteoporosis	0.000136	0.000459	CcSEcCtD
Telmisartan—Cough—Estradiol—osteoporosis	0.000136	0.000459	CcSEcCtD
Telmisartan—Constipation—Conjugated Estrogens—osteoporosis	0.000136	0.000459	CcSEcCtD
Telmisartan—Pain—Conjugated Estrogens—osteoporosis	0.000136	0.000459	CcSEcCtD
Telmisartan—Gastrointestinal pain—Zoledronate—osteoporosis	0.000135	0.000456	CcSEcCtD
Telmisartan—Hypertension—Estradiol—osteoporosis	0.000135	0.000454	CcSEcCtD
Telmisartan—Pruritus—Risedronate—osteoporosis	0.000134	0.000454	CcSEcCtD
Telmisartan—Nausea—Calcitriol—osteoporosis	0.000134	0.000453	CcSEcCtD
Telmisartan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000133	0.00045	CcSEcCtD
Telmisartan—Hypersensitivity—Pamidronate—osteoporosis	0.000133	0.00045	CcSEcCtD
Telmisartan—Arthralgia—Estradiol—osteoporosis	0.000133	0.000448	CcSEcCtD
Telmisartan—Myalgia—Estradiol—osteoporosis	0.000133	0.000448	CcSEcCtD
Telmisartan—Chest pain—Estradiol—osteoporosis	0.000133	0.000448	CcSEcCtD
Telmisartan—Anxiety—Estradiol—osteoporosis	0.000132	0.000446	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000132	0.000445	CcSEcCtD
Telmisartan—Urticaria—Zoledronate—osteoporosis	0.000131	0.000443	CcSEcCtD
Telmisartan—Discomfort—Estradiol—osteoporosis	0.000131	0.000443	CcSEcCtD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	0.000131	0.00208	CbGpPWpGaD
Telmisartan—Body temperature increased—Zoledronate—osteoporosis	0.00013	0.000441	CcSEcCtD
Telmisartan—Abdominal pain—Zoledronate—osteoporosis	0.00013	0.000441	CcSEcCtD
Telmisartan—Diarrhoea—Risedronate—osteoporosis	0.00013	0.000439	CcSEcCtD
Telmisartan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00013	0.000439	CcSEcCtD
Telmisartan—Dry mouth—Estradiol—osteoporosis	0.00013	0.000438	CcSEcCtD
Telmisartan—Asthenia—Pamidronate—osteoporosis	0.00013	0.000438	CcSEcCtD
Telmisartan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000129	0.000435	CcSEcCtD
Telmisartan—Pruritus—Pamidronate—osteoporosis	0.000128	0.000432	CcSEcCtD
Telmisartan—Oedema—Estradiol—osteoporosis	0.000127	0.000429	CcSEcCtD
Telmisartan—Anaphylactic shock—Estradiol—osteoporosis	0.000127	0.000429	CcSEcCtD
Telmisartan—Infection—Estradiol—osteoporosis	0.000126	0.000427	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000126	0.00201	CbGpPWpGaD
Telmisartan—Urticaria—Conjugated Estrogens—osteoporosis	0.000126	0.000426	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—FDPS—osteoporosis	0.000126	0.002	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PKM—osteoporosis	0.000126	0.002	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—osteoporosis	0.000126	0.002	CbGpPWpGaD
Telmisartan—Dizziness—Risedronate—osteoporosis	0.000126	0.000424	CcSEcCtD
Telmisartan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000126	0.000424	CcSEcCtD
Telmisartan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000126	0.000424	CcSEcCtD
Telmisartan—Shock—Estradiol—osteoporosis	0.000125	0.000423	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoporosis	0.000125	0.00198	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000125	0.00198	CbGpPWpGaD
Telmisartan—Nervous system disorder—Estradiol—osteoporosis	0.000125	0.000421	CcSEcCtD
Telmisartan—Tachycardia—Estradiol—osteoporosis	0.000124	0.000419	CcSEcCtD
Telmisartan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000124	0.000419	CcSEcCtD
Telmisartan—Diarrhoea—Pamidronate—osteoporosis	0.000124	0.000417	CcSEcCtD
Telmisartan—Skin disorder—Estradiol—osteoporosis	0.000124	0.000417	CcSEcCtD
Telmisartan—Hyperhidrosis—Estradiol—osteoporosis	0.000123	0.000415	CcSEcCtD
Telmisartan—Rash—Ethinyl Estradiol—osteoporosis	0.000123	0.000415	CcSEcCtD
Telmisartan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000123	0.000415	CcSEcCtD
Telmisartan—Headache—Ethinyl Estradiol—osteoporosis	0.000122	0.000412	CcSEcCtD
Telmisartan—Hypersensitivity—Zoledronate—osteoporosis	0.000122	0.000411	CcSEcCtD
Telmisartan—Vomiting—Risedronate—osteoporosis	0.000121	0.000408	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—SOST—osteoporosis	0.000121	0.00192	CbGpPWpGaD
Telmisartan—Rash—Risedronate—osteoporosis	0.00012	0.000405	CcSEcCtD
Telmisartan—Dermatitis—Risedronate—osteoporosis	0.00012	0.000404	CcSEcCtD
Telmisartan—PPARG—Gene Expression—U2AF1—osteoporosis	0.00012	0.0019	CbGpPWpGaD
Telmisartan—Dizziness—Pamidronate—osteoporosis	0.00012	0.000403	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—GPD2—osteoporosis	0.000119	0.0019	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PGLS—osteoporosis	0.000119	0.0019	CbGpPWpGaD
Telmisartan—Headache—Risedronate—osteoporosis	0.000119	0.000402	CcSEcCtD
Telmisartan—Asthenia—Zoledronate—osteoporosis	0.000118	0.0004	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000118	0.00187	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—WNT1—osteoporosis	0.000118	0.00187	CbGpPWpGaD
Telmisartan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000117	0.000395	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—LEP—osteoporosis	0.000117	0.00186	CbGpPWpGaD
Telmisartan—Pruritus—Zoledronate—osteoporosis	0.000117	0.000394	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—osteoporosis	0.000117	0.00185	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000116	0.000391	CcSEcCtD
Telmisartan—Nausea—Ethinyl Estradiol—osteoporosis	0.000116	0.000391	CcSEcCtD
Telmisartan—Insomnia—Estradiol—osteoporosis	0.000115	0.000388	CcSEcCtD
Telmisartan—Vomiting—Pamidronate—osteoporosis	0.000115	0.000388	CcSEcCtD
Telmisartan—Paraesthesia—Estradiol—osteoporosis	0.000114	0.000386	CcSEcCtD
Telmisartan—Asthenia—Conjugated Estrogens—osteoporosis	0.000114	0.000385	CcSEcCtD
Telmisartan—Rash—Pamidronate—osteoporosis	0.000114	0.000385	CcSEcCtD
Telmisartan—Dermatitis—Pamidronate—osteoporosis	0.000114	0.000384	CcSEcCtD
Telmisartan—Dyspnoea—Estradiol—osteoporosis	0.000113	0.000383	CcSEcCtD
Telmisartan—Headache—Pamidronate—osteoporosis	0.000113	0.000382	CcSEcCtD
Telmisartan—Somnolence—Estradiol—osteoporosis	0.000113	0.000382	CcSEcCtD
Telmisartan—Diarrhoea—Zoledronate—osteoporosis	0.000113	0.000381	CcSEcCtD
Telmisartan—Nausea—Risedronate—osteoporosis	0.000113	0.000381	CcSEcCtD
Telmisartan—Pruritus—Conjugated Estrogens—osteoporosis	0.000112	0.00038	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000112	0.00179	CbGpPWpGaD
Telmisartan—Dyspepsia—Estradiol—osteoporosis	0.000112	0.000378	CcSEcCtD
Telmisartan—Decreased appetite—Estradiol—osteoporosis	0.000111	0.000373	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00011	0.00175	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Estradiol—osteoporosis	0.00011	0.000371	CcSEcCtD
Telmisartan—Fatigue—Estradiol—osteoporosis	0.00011	0.00037	CcSEcCtD
Telmisartan—Dizziness—Zoledronate—osteoporosis	0.000109	0.000369	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—PNP—osteoporosis	0.000109	0.00173	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ATIC—osteoporosis	0.000109	0.00173	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CALCR—osteoporosis	0.000109	0.00173	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTH1R—osteoporosis	0.000109	0.00173	CbGpPWpGaD
Telmisartan—Constipation—Estradiol—osteoporosis	0.000109	0.000367	CcSEcCtD
Telmisartan—Pain—Estradiol—osteoporosis	0.000109	0.000367	CcSEcCtD
Telmisartan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000109	0.000367	CcSEcCtD
Telmisartan—PPARG—Metabolism—FDPS—osteoporosis	0.000107	0.00171	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PKM—osteoporosis	0.000107	0.00171	CbGpPWpGaD
Telmisartan—Nausea—Pamidronate—osteoporosis	0.000107	0.000362	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—PTH—osteoporosis	0.000107	0.0017	CbGpPWpGaD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000107	0.0017	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000106	0.00169	CbGpPWpGaD
Telmisartan—Dizziness—Conjugated Estrogens—osteoporosis	0.000105	0.000355	CcSEcCtD
Telmisartan—Vomiting—Zoledronate—osteoporosis	0.000105	0.000354	CcSEcCtD
Telmisartan—Feeling abnormal—Estradiol—osteoporosis	0.000105	0.000354	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—CNR2—osteoporosis	0.000104	0.00165	CbGpPWpGaD
Telmisartan—Rash—Zoledronate—osteoporosis	0.000104	0.000351	CcSEcCtD
Telmisartan—Gastrointestinal pain—Estradiol—osteoporosis	0.000104	0.000351	CcSEcCtD
Telmisartan—Dermatitis—Zoledronate—osteoporosis	0.000104	0.000351	CcSEcCtD
Telmisartan—Headache—Zoledronate—osteoporosis	0.000103	0.000349	CcSEcCtD
Telmisartan—PPARG—Metabolism—GPD2—osteoporosis	0.000102	0.00162	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PGLS—osteoporosis	0.000102	0.00162	CbGpPWpGaD
Telmisartan—Vomiting—Conjugated Estrogens—osteoporosis	0.000101	0.000341	CcSEcCtD
Telmisartan—Urticaria—Estradiol—osteoporosis	0.000101	0.000341	CcSEcCtD
Telmisartan—Abdominal pain—Estradiol—osteoporosis	0.000101	0.00034	CcSEcCtD
Telmisartan—Body temperature increased—Estradiol—osteoporosis	0.000101	0.00034	CcSEcCtD
Telmisartan—Rash—Conjugated Estrogens—osteoporosis	0.0001	0.000338	CcSEcCtD
Telmisartan—Dermatitis—Conjugated Estrogens—osteoporosis	0.0001	0.000338	CcSEcCtD
Telmisartan—Headache—Conjugated Estrogens—osteoporosis	9.96e-05	0.000336	CcSEcCtD
Telmisartan—Nausea—Zoledronate—osteoporosis	9.8e-05	0.000331	CcSEcCtD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.74e-05	0.00155	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PTH—osteoporosis	9.7e-05	0.00154	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—ESR2—osteoporosis	9.53e-05	0.00151	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	9.47e-05	0.0015	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CNR2—osteoporosis	9.45e-05	0.0015	CbGpPWpGaD
Telmisartan—Nausea—Conjugated Estrogens—osteoporosis	9.44e-05	0.000319	CcSEcCtD
Telmisartan—Hypersensitivity—Estradiol—osteoporosis	9.37e-05	0.000316	CcSEcCtD
Telmisartan—PPARG—Metabolism—ATIC—osteoporosis	9.31e-05	0.00148	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PNP—osteoporosis	9.31e-05	0.00148	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—OXCT1—osteoporosis	9.28e-05	0.00147	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CA2—osteoporosis	9.28e-05	0.00147	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.23e-05	0.00147	CbGpPWpGaD
Telmisartan—Asthenia—Estradiol—osteoporosis	9.13e-05	0.000308	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—MGLL—osteoporosis	9.04e-05	0.00144	CbGpPWpGaD
Telmisartan—Pruritus—Estradiol—osteoporosis	9e-05	0.000304	CcSEcCtD
Telmisartan—PPARG—Gene Expression—RPL24—osteoporosis	8.9e-05	0.00141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—WNT1—osteoporosis	8.89e-05	0.00141	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PTHLH—osteoporosis	8.85e-05	0.00141	CbGpPWpGaD
Telmisartan—Diarrhoea—Estradiol—osteoporosis	8.7e-05	0.000294	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—MGLL—osteoporosis	8.66e-05	0.00138	CbGpPWpGaD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.66e-05	0.00138	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.53e-05	0.00135	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LRP5—osteoporosis	8.46e-05	0.00134	CbGpPWpGaD
Telmisartan—Dizziness—Estradiol—osteoporosis	8.41e-05	0.000284	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—TGFB1—osteoporosis	8.21e-05	0.0013	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LRP6—osteoporosis	8.09e-05	0.00129	CbGpPWpGaD
Telmisartan—Vomiting—Estradiol—osteoporosis	8.09e-05	0.000273	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—PTHLH—osteoporosis	8.04e-05	0.00128	CbGpPWpGaD
Telmisartan—Rash—Estradiol—osteoporosis	8.02e-05	0.000271	CcSEcCtD
Telmisartan—Dermatitis—Estradiol—osteoporosis	8.01e-05	0.000271	CcSEcCtD
Telmisartan—Headache—Estradiol—osteoporosis	7.97e-05	0.000269	CcSEcCtD
Telmisartan—PPARG—Metabolism—CA2—osteoporosis	7.92e-05	0.00126	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—OXCT1—osteoporosis	7.92e-05	0.00126	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PKM—osteoporosis	7.83e-05	0.00124	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—FDPS—osteoporosis	7.83e-05	0.00124	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CALCA—osteoporosis	7.79e-05	0.00124	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MGLL—osteoporosis	7.71e-05	0.00123	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—IDH2—osteoporosis	7.69e-05	0.00122	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TNF—osteoporosis	7.67e-05	0.00122	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	7.65e-05	0.00122	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—VDR—osteoporosis	7.56e-05	0.0012	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	7.56e-05	0.0012	CbGpPWpGaD
Telmisartan—Nausea—Estradiol—osteoporosis	7.56e-05	0.000255	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	7.55e-05	0.0012	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPD2—osteoporosis	7.42e-05	0.00118	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PGLS—osteoporosis	7.42e-05	0.00118	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.27e-05	0.00116	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP27A1—osteoporosis	7.23e-05	0.00115	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—POMC—osteoporosis	7.21e-05	0.00115	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.18e-05	0.00114	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	7.08e-05	0.00113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CALCA—osteoporosis	7.08e-05	0.00112	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ACP5—osteoporosis	7.03e-05	0.00112	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7e-05	0.00111	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.94e-05	0.0011	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TLN1—osteoporosis	6.83e-05	0.00109	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ATIC—osteoporosis	6.79e-05	0.00108	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PNP—osteoporosis	6.79e-05	0.00108	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.62e-05	0.00105	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—IDH2—osteoporosis	6.56e-05	0.00104	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TPI1—osteoporosis	6.54e-05	0.00104	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFB1—osteoporosis	6.28e-05	0.000997	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL1B—osteoporosis	6.21e-05	0.000986	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IL6—osteoporosis	6.19e-05	0.000983	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP27A1—osteoporosis	6.17e-05	0.00098	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—P4HB—osteoporosis	6.15e-05	0.000976	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GAPDH—osteoporosis	6.03e-05	0.000958	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ACP5—osteoporosis	6e-05	0.000953	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.94e-05	0.000944	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.92e-05	0.000941	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—P4HB—osteoporosis	5.89e-05	0.000936	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—RAP1A—osteoporosis	5.88e-05	0.000934	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—ESR1—osteoporosis	5.78e-05	0.000918	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA2—osteoporosis	5.77e-05	0.000917	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—OXCT1—osteoporosis	5.77e-05	0.000917	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTH—osteoporosis	5.73e-05	0.00091	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—LEP—osteoporosis	5.7e-05	0.000905	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAP1A—osteoporosis	5.63e-05	0.000895	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MGLL—osteoporosis	5.62e-05	0.000894	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.59e-05	0.000889	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CNR2—osteoporosis	5.58e-05	0.000887	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TPI1—osteoporosis	5.58e-05	0.000886	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	5.56e-05	0.000883	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—ADCY5—osteoporosis	5.54e-05	0.000881	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFATC1—osteoporosis	5.49e-05	0.000873	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—DKK1—osteoporosis	5.45e-05	0.000866	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—WNT1—osteoporosis	5.25e-05	0.000834	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—P4HB—osteoporosis	5.24e-05	0.000833	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GAPDH—osteoporosis	5.15e-05	0.000818	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PSMA5—osteoporosis	5.14e-05	0.000816	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PSMA2—osteoporosis	5.14e-05	0.000816	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.12e-05	0.000814	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGA—osteoporosis	5.11e-05	0.000811	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—ADCY5—osteoporosis	5.03e-05	0.0008	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—RAP1A—osteoporosis	5.01e-05	0.000796	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TGFB1—osteoporosis	4.82e-05	0.000766	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—IDH2—osteoporosis	4.78e-05	0.00076	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6R—osteoporosis	4.78e-05	0.000759	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.76e-05	0.000756	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ENO1—osteoporosis	4.75e-05	0.000755	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTHLH—osteoporosis	4.75e-05	0.000754	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BMP2—osteoporosis	4.75e-05	0.000754	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.74e-05	0.000753	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PSMA2—osteoporosis	4.68e-05	0.000744	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PSMA5—osteoporosis	4.68e-05	0.000744	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGB—osteoporosis	4.65e-05	0.000738	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—POMC—osteoporosis	4.6e-05	0.000731	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ESR2—osteoporosis	4.59e-05	0.000729	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.59e-05	0.000729	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—osteoporosis	4.5e-05	0.000715	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP27A1—osteoporosis	4.5e-05	0.000714	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PSMA2—osteoporosis	4.48e-05	0.000713	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PSMA5—osteoporosis	4.48e-05	0.000713	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ACP5—osteoporosis	4.37e-05	0.000695	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.37e-05	0.000695	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—osteoporosis	4.37e-05	0.000694	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PKM—osteoporosis	4.34e-05	0.000689	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—FDPS—osteoporosis	4.34e-05	0.000689	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PKM—osteoporosis	4.23e-05	0.000673	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—FDPS—osteoporosis	4.23e-05	0.000673	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CALCA—osteoporosis	4.18e-05	0.000664	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.12e-05	0.000655	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PGLS—osteoporosis	4.11e-05	0.000653	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPD2—osteoporosis	4.11e-05	0.000653	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—POMC—osteoporosis	4.08e-05	0.000648	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TPI1—osteoporosis	4.07e-05	0.000646	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ENO1—osteoporosis	4.05e-05	0.000644	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PGLS—osteoporosis	4.01e-05	0.000638	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPD2—osteoporosis	4.01e-05	0.000638	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PSMA2—osteoporosis	3.99e-05	0.000634	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PSMA5—osteoporosis	3.99e-05	0.000634	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.97e-05	0.000631	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—P4HB—osteoporosis	3.82e-05	0.000607	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP19A1—osteoporosis	3.8e-05	0.000603	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KL—osteoporosis	3.8e-05	0.000603	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ATIC—osteoporosis	3.76e-05	0.000597	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PNP—osteoporosis	3.76e-05	0.000597	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GAPDH—osteoporosis	3.75e-05	0.000596	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—POMC—osteoporosis	3.7e-05	0.000588	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PNP—osteoporosis	3.67e-05	0.000583	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ATIC—osteoporosis	3.67e-05	0.000583	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—RAP1A—osteoporosis	3.66e-05	0.000581	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—VDR—osteoporosis	3.64e-05	0.000579	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6R—osteoporosis	3.61e-05	0.000574	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP19A1—osteoporosis	3.24e-05	0.000515	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA2—osteoporosis	3.2e-05	0.000508	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—OXCT1—osteoporosis	3.2e-05	0.000508	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—OXCT1—osteoporosis	3.12e-05	0.000496	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA2—osteoporosis	3.12e-05	0.000496	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MGLL—osteoporosis	3.12e-05	0.000495	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ADCY5—osteoporosis	3.1e-05	0.000493	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GPX1—osteoporosis	3.09e-05	0.000491	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MGLL—osteoporosis	3.04e-05	0.000483	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—osteoporosis	3.01e-05	0.000478	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADCY5—osteoporosis	2.97e-05	0.000472	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ENO1—osteoporosis	2.95e-05	0.000469	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.94e-05	0.000467	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PSMA2—osteoporosis	2.91e-05	0.000463	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PSMA5—osteoporosis	2.91e-05	0.000463	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SPP1—osteoporosis	2.88e-05	0.000457	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—MTHFR—osteoporosis	2.85e-05	0.000453	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—osteoporosis	2.82e-05	0.000449	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ESR1—osteoporosis	2.78e-05	0.000442	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—IDH2—osteoporosis	2.65e-05	0.000421	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ADCY5—osteoporosis	2.65e-05	0.000421	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GPX1—osteoporosis	2.64e-05	0.000419	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—osteoporosis	2.64e-05	0.000419	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IRS2—osteoporosis	2.6e-05	0.000413	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—IDH2—osteoporosis	2.59e-05	0.000411	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LEP—osteoporosis	2.55e-05	0.000404	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.49e-05	0.000396	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—osteoporosis	2.43e-05	0.000387	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP27A1—osteoporosis	2.43e-05	0.000386	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ESR1—osteoporosis	2.43e-05	0.000386	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ACP5—osteoporosis	2.42e-05	0.000385	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.39e-05	0.00038	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.39e-05	0.000379	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.38e-05	0.000378	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ACP5—osteoporosis	2.37e-05	0.000376	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP19A1—osteoporosis	2.36e-05	0.000375	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—POMC—osteoporosis	2.28e-05	0.000363	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IRS1—osteoporosis	2.27e-05	0.000361	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TPI1—osteoporosis	2.25e-05	0.000358	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.23e-05	0.000354	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.22e-05	0.000353	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TPI1—osteoporosis	2.2e-05	0.000349	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—POMC—osteoporosis	2.19e-05	0.000347	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6R—osteoporosis	2.13e-05	0.000339	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—osteoporosis	2.13e-05	0.000338	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—P4HB—osteoporosis	2.12e-05	0.000336	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1—osteoporosis	2.1e-05	0.000334	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GAPDH—osteoporosis	2.08e-05	0.00033	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—P4HB—osteoporosis	2.07e-05	0.000328	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GAPDH—osteoporosis	2.03e-05	0.000322	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RAP1A—osteoporosis	2.02e-05	0.000322	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RAP1A—osteoporosis	1.98e-05	0.000314	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—POMC—osteoporosis	1.95e-05	0.000309	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ADCY5—osteoporosis	1.93e-05	0.000307	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPX1—osteoporosis	1.92e-05	0.000306	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—osteoporosis	1.78e-05	0.000282	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.77e-05	0.000281	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO1—osteoporosis	1.64e-05	0.00026	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PSMA5—osteoporosis	1.61e-05	0.000256	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PSMA2—osteoporosis	1.61e-05	0.000256	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—osteoporosis	1.61e-05	0.000256	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO1—osteoporosis	1.6e-05	0.000254	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PSMA2—osteoporosis	1.57e-05	0.00025	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PSMA5—osteoporosis	1.57e-05	0.00025	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—osteoporosis	1.45e-05	0.00023	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—POMC—osteoporosis	1.42e-05	0.000226	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.31e-05	0.000208	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP19A1—osteoporosis	1.28e-05	0.000203	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—osteoporosis	1.26e-05	0.000201	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—osteoporosis	1.26e-05	0.0002	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADCY5—osteoporosis	1.07e-05	0.00017	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX1—osteoporosis	1.07e-05	0.000169	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADCY5—osteoporosis	1.04e-05	0.000166	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX1—osteoporosis	1.04e-05	0.000165	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—osteoporosis	9.83e-06	0.000156	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—osteoporosis	9.6e-06	0.000152	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—osteoporosis	9.5e-06	0.000151	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—POMC—osteoporosis	7.86e-06	0.000125	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—POMC—osteoporosis	7.68e-06	0.000122	CbGpPWpGaD
